The global AI in Medical Imaging market size was valued at USD 1862.4 million in 2025 and is projected to reach USD 35285.6 million by 2035, expanding at a CAGR of 34.2% from 2026 to 2035. Market growth is supported by the rising adoption of AI-enabled diagnostic imaging solutions, increasing demand for early disease detection, advancements in deep learning technologies, and growing investments in healthcare digitalization and workflow automation.
|
Years |
2022 |
2023 |
2024 |
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
Revenue (USD Mn) |
770.5 |
XX |
XX |
1862.4 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
35285.6 |
|
Region |
2022 |
2023 |
2024 |
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
North America |
XX |
XX |
XX |
841.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
13519.1 |
|
Europe |
XX |
XX |
XX |
502.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
8386.7 |
|
Asia Pacific |
XX |
XX |
XX |
383.6 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
8427.7 |
|
Latin America |
XX |
XX |
XX |
65.1 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
1207.6 |
|
Middle East & Africa |
XX |
XX |
XX |
68.9 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
1211.4 |
|
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
|
Conservative |
1134.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
18643 |
|
Likely |
1862.4 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
35285.6 |
|
Optimistic |
1134.8 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
28425.6 |
The growing global burden of chronic diseases is substantially increasing demand for diagnostic imaging, creating a strong foundation for AI adoption in medical imaging workflows. According to the OECD'sHealth at a Glance 2025, the number of CT and MRI examinations per 1,000 population has continued to rise across several major healthcare markets. 6.4, CT examinations more than doubled in South Korea and increased by over 50% in Australia, while MRI examinations more than doubled in South Korea and Latvia and grew by approximately 70% in France. This sustained increase reflects the growing reliance on advanced imaging for diagnosing cancer, cardiovascular diseases, neurological disorders, and respiratory conditions.
Furthermore, Canada's healthcare system performed approximately 6.4 million publicly funded CT examinations during FY 2022–2023, representing a 9% increase since 2015, according to the Canadian Medical Imaging Inventory. As imaging volumes continue to expand, healthcare providers face mounting pressure to deliver faster and more accurate diagnoses. AI-powered image analysis, automated triage, and workflow optimization tools are increasingly being deployed to manage this growing workload, improve reporting efficiency, and reduce diagnostic delays. Consequently, the continuous rise in diagnostic imaging utilization worldwide remains one of the most significant growth drivers for the AI in Medical Imaging Market.
(Source: , https://www.ncbi.nlm.nih.gov/books/NBK607343/)
A persistent shortage of radiologists worldwide is driving healthcare providers to adopt AI solutions that improve productivity, automate repetitive tasks, and optimize imaging workflows. According to the American College of Radiology (ACR), imaging demand continues to increase as populations age and healthcare systems perform higher volumes of diagnostic procedures, placing significant pressure on existing radiology workforces. Research published in Nature npj Imaging highlights that radiologists are facing increasing workloads, leading to longer examination wait times and delays in diagnosis and treatment. Similar workforce challenges are being reported globally.
In the United Kingdom, research cited in a systematic review found that the clinical radiology workforce grows by only 3% annually, while demand for diagnostic imaging continues to rise at a much faster pace. In South Africa, healthcare systems operate with only one radiologist per 100,000 people, creating substantial diagnostic capacity constraints. These workforce shortages are encouraging hospitals and imaging centers to implement AI-powered solutions for image prioritization, abnormality detection, report generation, and workflow automation. As healthcare providers seek scalable approaches to address staffing gaps while maintaining diagnostic accuracy and operational efficiency, AI is increasingly viewed as a critical enabling technology, thereby accelerating growth across the global AI in Medical Imaging Market.
The adoption of AI in medical imaging relies heavily on access to vast amounts of patient imaging data, creating significant concerns around data privacy, cybersecurity, and regulatory compliance. Healthcare remains one of the most targeted industries for cyberattacks due to the high value of patient information.
According to the U.S. healthcare breach statistics reported by the Office for Civil Rights (OCR), hacking-related healthcare data breaches increased by 239% between 2018 and 2023, while ransomware attacks increased by 278% during the same period. Furthermore, a recent healthcare cybersecurity analysis reported that approximately 275 million healthcare records were breached in 2024, highlighting the growing vulnerability of digital healthcare ecosystems.
AI-based imaging platforms often require integration with Picture Archiving and Communication Systems (PACS), Electronic Health Records (EHRs), and cloud infrastructure, increasing the potential attack surface for cybercriminals. Healthcare providers must also comply with strict regulations such as HIPAA in the United States and GDPR in Europe, which can slow AI deployment and increase implementation costs.
Concerns regarding unauthorized access to medical images, patient consent management, cross-border data sharing, and algorithm training using sensitive health data continue to create barriers to adoption. As healthcare organizations become increasingly cautious about data governance and cybersecurity investments, privacy and security concerns remain a significant restraint on the growth of the AI in Medical Imaging Market.
(Sources:https://www.hipaajournal.com/healthcare-data-breach-statistics/, https://www.techradar.com/pro/healthcare-cyber-risk-in-2026-what-the-claims-data-actually-shows, https://pmc.ncbi.nlm.nih.gov/articles/PMC10718098/ )
Despite significant technological advancements, concerns regarding algorithm reliability, clinical validation, and regulatory oversight continue to limit widespread adoption of AI in medical imaging. AI systems must demonstrate consistent performance across diverse patient populations, imaging devices, and clinical environments before they can be trusted in routine healthcare settings. However, evidence suggests that AI-enabled medical devices can still encounter performance and safety challenges. According to a recent Reuters investigation, the U.S. FDA received at least 1,401 adverse event reports related to AI-enabled medical devices between 2021 and 2025, including over 115 reports specifically involving software, algorithm, or programming issues. The report also highlighted more than 100 incidents and at least 10 patient injuries associated with one AI-assisted navigation system used in surgical procedures. In medical imaging, false positives, false negatives, and algorithm bias can directly affect diagnostic accuracy, creating hesitation among healthcare providers. Furthermore, healthcare institutions often require extensive validation studies before integrating AI into clinical workflows, which can significantly lengthen deployment timelines. Regulatory agencies worldwide are also continuously updating their frameworks for AI-based medical software, creating uncertainty for developers and healthcare organizations. These challenges increase development costs, delay commercialization, and slow adoption rates, making regulatory complexity and clinical reliability one of the most important restraints in the AI in Medical Imaging Market.
The rapid shift toward cloud-enabled healthcare infrastructure is creating significant opportunities for AI in Medical Imaging Market. AI algorithms require access to large, diverse, and interoperable imaging datasets to improve diagnostic accuracy and clinical utility. The World Health Organization (WHO) continues to promote digital health adoption and interoperability standards to facilitate data sharing and evidence-based healthcare decision-making. As healthcare providers increasingly migrate imaging archives and workflows to cloud environments, AI developers gain access to scalable computing resources and centralized imaging datasets for algorithm training and deployment.
Major technology providers are also investing heavily in cloud-based medical imaging solutions that improve accessibility, interoperability, and AI integration capabilities. Furthermore, a 2024 study published in Electronics found that cloud-based deep learning systems improved diagnostic accuracy by an average of 15–20% while reducing medical data processing time by approximately 60%. The same study reported that healthcare organizations implementing phased cloud deployment strategies achieved 90% successful integration rates, highlighting the growing feasibility of cloud-enabled AI adoption. As healthcare systems increasingly seek scalable solutions to manage rising imaging volumes and facilitate collaboration across hospitals, diagnostic centers, and research institutions, cloud-native imaging platforms are expected to create substantial long-term growth opportunities for AI vendors and healthcare providers alike.
(Source: https://www.mdpi.com/2079-9292/13/24/4860, )
|
By Technology |
2025 |
|
Deep Learning |
68.4% |
|
Natural Language Processing (NLP) |
18.7% |
|
Others |
12.9% |
Deep Learning dominated the AI in Medical Imaging Market due to its superior capability to analyze complex medical images with high accuracy and speed. The technology is widely used for image recognition, lesion detection, segmentation, and diagnostic decision support across radiology, oncology, cardiology, and neurology applications. Continuous advancements in neural network architectures and growing clinical adoption further strengthen its market leadership.
Natural Language Processing (NLP) is projected to be the fastest-growing segment owing to its increasing use in radiology reporting, clinical documentation, speech recognition, and workflow automation. Healthcare providers are adopting NLP solutions to extract insights from unstructured medical records and improve reporting efficiency. The integration of generative AI and large language models is further accelerating segment growth.
Neurology accounted for the largest share of the AI in Medical Imaging Market due to the extensive use of AI for stroke detection, brain hemorrhage identification, tumor assessment, and neurodegenerative disease diagnosis. Growing prevalence of neurological disorders and increasing adoption of AI-enabled MRI and CT image analysis solutions have significantly enhanced diagnostic accuracy and treatment planning capabilities.
Cardiology is expected to register the fastest growth during the forecast period, driven by the rising global burden of cardiovascular diseases and increasing demand for early diagnosis. AI technologies are increasingly utilized in echocardiography, cardiac CT, and MRI analysis to improve workflow efficiency, automate measurements, and support clinical decision-making, thereby accelerating adoption across healthcare facilities.
CT Scan represented the largest segment in the AI in Medical Imaging Market owing to its widespread use in diagnosing neurological, cardiovascular, oncological, and trauma-related conditions. AI-powered CT imaging solutions are extensively deployed for rapid image interpretation, stroke detection, lung disease assessment, and workflow prioritization. High scan volumes and growing emergency care applications continue to support the segment’s dominant position.
MRI is anticipated to be the fastest-growing segment due to increasing demand for high-resolution imaging in neurology, oncology, and musculoskeletal diagnostics. AI integration helps accelerate image acquisition, improve image quality, automate segmentation, and enhance diagnostic accuracy. Rising adoption of advanced MRI technologies and growing emphasis on precision diagnostics are further contributing to the segment’s rapid expansion.
Hospitals held the largest share of the AI in Medical Imaging Market due to their high patient volumes, extensive imaging infrastructure, and strong investments in advanced diagnostic technologies. These facilities increasingly deploy AI solutions to improve image interpretation, optimize radiology workflows, reduce reporting turnaround times, and enhance clinical decision-making across multiple specialties, supporting their dominant market position.
Diagnostic Imaging Centers are projected to be the fastest-growing segment, driven by rising demand for outpatient imaging services and the need for operational efficiency. AI-powered imaging tools enable faster scan analysis, improved diagnostic accuracy, and higher patient throughput. Growing adoption of cloud-based AI platforms and expanding preventive screening programs are further accelerating growth in this segment.
|
By Geography |
2022 |
2025 |
2035 |
|
North America |
XX |
841.8 |
XX |
|
US |
XX |
779.5 |
XX |
|
Canada |
XX |
62.2 |
XX |
|
Europe |
XX |
502.8 |
XX |
|
Germany |
XX |
103 |
XX |
|
UK |
XX |
64.3 |
XX |
|
France |
XX |
78.4 |
XX |
|
Italy |
XX |
43.2 |
XX |
|
Spain |
XX |
41.2 |
XX |
|
Switzerland |
XX |
15.5 |
XX |
|
Netherlands |
XX |
10.5 |
XX |
|
Rest of Europe |
XX |
146.3 |
XX |
|
Asia Pacific |
XX |
383.6 |
XX |
|
China |
XX |
160.7 |
XX |
|
India |
XX |
29.1 |
XX |
|
Japan |
XX |
60.6 |
XX |
|
South Korea |
XX |
54.8 |
XX |
|
Singapore |
XX |
13.8 |
XX |
|
Australia |
XX |
19.9 |
XX |
|
Thailand |
XX |
4.9 |
XX |
|
Malaysia |
XX |
9.5 |
XX |
|
Philippines |
XX |
7.6 |
XX |
|
Indonesia |
XX |
6.1 |
XX |
|
Rest of Asia Pacific |
XX |
16.1 |
XX |
|
Middle East & Africa |
XX |
68.9 |
XX |
|
Saudi Arabia |
XX |
22.6 |
XX |
|
United Arab Emirates |
XX |
17.8 |
XX |
|
South Africa |
XX |
10.4 |
XX |
|
Egypt |
XX |
5.6 |
XX |
|
Israel |
XX |
7.4 |
XX |
|
Rest of MEA |
XX |
22.6 |
XX |
|
Latin America |
XX |
65.1 |
XX |
|
Brazil |
XX |
21.4 |
XX |
|
Mexico |
XX |
15.3 |
XX |
|
Argentina |
XX |
6.9 |
XX |
|
Chile |
XX |
5.6 |
XX |
|
Colombia |
XX |
3.3 |
XX |
|
Peru |
XX |
2.8 |
XX |
|
Rest of LA |
XX |
9.7 |
XX |
North America AI in Medical Imaging market held the largest share of 45.2% of the global market in 2025 and was valued at approximately USD 841.8 million. The regional market is primarily driven by the widespread adoption of AI-enabled diagnostic imaging solutions, strong healthcare IT infrastructure, increasing imaging procedure volumes, and the presence of leading healthcare technology innovators.
The U.S. accounted for the dominant share within North America and represented approximately 92.6% of the regional market in 2025. Market growth is driven by increasing FDA-cleared imaging AI solutions, high healthcare expenditure, growing radiology workflow automation, and strong investments in healthcare artificial intelligence technologies.
Canada represented approximately 7.4% of the North American market in 2025 and was valued at around USD 62.2 million. Market expansion is supported by rising adoption of digital health platforms, growing demand for diagnostic imaging services, increasing utilization of teleradiology, and government-backed healthcare innovation initiatives.
Europe accounted for approximately 27% of the global AI in Medical Imaging market in 2025 and was valued at nearly USD 502.8 million. The regional market is supported by growing investments in healthcare digitalization, increasing utilization of AI-assisted radiology workflows, favourable research initiatives, and rising demand for precision diagnostics across healthcare systems.
The UK represented approximately 12.8% of the European market in 2025 and was valued at nearly USD 64.3 million. Market growth is supported by NHS-led AI adoption initiatives, increasing imaging demand, expansion of community diagnostic centers, and growing focus on reducing diagnostic backlogs.
Germany accounted for approximately 20.5% of the European market in 2025 and was valued at around USD 103 million. The market is driven by advanced healthcare infrastructure, increasing deployment of AI-powered diagnostic systems, strong medical technology expertise, and growing investments in hospital digital transformation.
The France represented approximately 15.6% of the European market in 2025 and was valued at nearly USD 78.4 million. The market benefits from increasing healthcare digitalization, rising use of AI in radiology workflows, growing precision medicine initiatives, and strong public-sector support for healthcare innovation.
Italy accounted for approximately 8.6% of the European market in 2025 and was valued at around USD 43.2 million. Market expansion is driven by increasing demand for automated diagnostic solutions, rising prevalence of chronic diseases, growing healthcare modernization efforts, and expanding adoption of advanced imaging technologies.
The Spain represented approximately 8.2 % of the European market in 2025 and was valued at nearly USD 41.2 million. The market is supported by investments in smart healthcare infrastructure, increasing implementation of AI-enabled screening programs, growing imaging volumes, and healthcare digital transformation initiatives.
Switzerland accounted for approximately 3.1 % of the European market in 2025 and was valued at around USD 15.5 million. Market growth is driven by a strong healthcare innovation ecosystem, increasing adoption of advanced imaging technologies, significant research activities, and growing investments in precision healthcare.
The Netherlands represented approximately 2.1 % of the European market in 2025 and was valued at nearly USD 10.5 million. The market benefits from advanced digital health infrastructure, increasing demand for workflow automation, growing data-driven healthcare initiatives, and strong support for healthcare innovation programs.
Asia-Pacific accounted for approximately 20.6% of the global market in 2025 and was valued at nearly USD 383.6 million. The regional market is fueled by rapid healthcare infrastructure development, expanding adoption of digital health technologies, growing diagnostic imaging demand, and increasing government support for artificial intelligence in healthcare.
China represented approximately 41.9 % of the Asia-Pacific market in 2025 and was valued at around USD 160.7 million. Market growth is fuelled by national AI development initiatives, rapid expansion of smart hospitals, increasing diagnostic imaging volumes, and strong domestic innovation in healthcare technologies.
India accounted for approximately 7.6 % of the Asia-Pacific market in 2025 and was valued at nearly USD 29.1 million. The market is driven by growing demand for affordable diagnostic services, expansion of digital healthcare programs, increasing adoption of teleradiology, and rising investments in healthcare technology.
Japan represented approximately 15.8 % of the Asia-Pacific market in 2025 and was valued at around USD 60.6 million. Market expansion is supported by an aging population, increasing need for diagnostic imaging services, strong adoption of advanced medical technologies, and growing healthcare automation initiatives.
South Korea represented approximately 14.3 % of the Asia-Pacific market in 2025 and was valued at around USD 54.8 million. The market benefits from government support for healthcare AI, advanced digital healthcare infrastructure, increasing adoption of smart hospital technologies, and strong innovation capabilities.
Singapore accounted for approximately 3.6 % of the Asia-Pacific market in 2025 and was valued at nearly USD 13.8 million. Market growth is driven by Smart Nation healthcare initiatives, advanced healthcare IT systems, increasing focus on precision medicine, and strong public-private healthcare collaborations.
Australia represented approximately 5.2 % of the Asia-Pacific market in 2025 and was valued at around USD 19.9 million. The market is supported by rising demand for remote diagnostic services, growing AI adoption in radiology networks, healthcare digitalization programs, and increasing chronic disease prevalence.
Thailand represented approximately 1.3 % of the Asia-Pacific market in 2025 and was valued at around USD 4.9 million. Market expansion is fueled by medical tourism growth, modernization of healthcare facilities, increasing diagnostic imaging demand, and rising adoption of digital healthcare technologies.
Malaysia accounted for approximately 2.5 % of the Asia-Pacific market in 2025 and was valued at nearly USD 9.5 million. The market is driven by healthcare digital transformation programs, growing deployment of enterprise imaging solutions, rising demand for efficient diagnostics, and expanding private healthcare investments.
Philippines represented approximately 2 % of the Asia-Pacific market in 2025 and was valued at around USD 7.6 million. Market growth is supported by increasing healthcare infrastructure investments, growing telehealth adoption, rising diagnostic imaging utilization, and expansion of private healthcare services.
Indonesia represented approximately 1.6 % of the Asia-Pacific market in 2025 and was valued at around USD 6.1 million. The market benefits from expanding healthcare coverage programs, increasing hospital digitization efforts, growing demand for early disease detection, and investments in healthcare modernization.
Middle East & Africa accounted for approximately 3.7% of the global market in 2025 and was valued at nearly USD 68.9 million. The regional market is driven by ongoing healthcare modernization initiatives, increasing investments in smart hospital projects, growing demand for advanced diagnostic services, and rising adoption of digital healthcare technologies.
Saudi Arabia accounted for approximately 32.8 % of the Middle East market in 2025 and was valued at nearly USD 22.6 million. Market growth is driven by Vision 2030 healthcare initiatives, increasing investments in smart hospitals, rising demand for advanced diagnostics, and expansion of healthcare digital transformation projects.
United Arab Emirates represented approximately 25.9 % of the Middle East market in 2025 and was valued at around USD 17.8 million. The market is supported by strong government focus on healthcare innovation, growing AI adoption across healthcare facilities, expansion of digital health ecosystems, and increasing medical tourism activities.
South Africa represented approximately 15.1 % of the Middle East market in 2025 and was valued at around USD 10.4 million. Market expansion is fuelled by rising demand for diagnostic services, increasing healthcare digitization efforts, growing private healthcare investments, and the need to improve healthcare accessibility.
Egypt accounted for approximately 8.2 % of the Middle East & Africa market in 2025 and was valued at nearly USD 5.6 million. The market is driven by healthcare infrastructure development, increasing demand for early disease diagnosis, expansion of healthcare reform initiatives, and rising adoption of digital health technologies.
Israel represented approximately 7.2 % of the Middle East and Africa market in 2025 and was valued at around USD 4.9 million. Market growth is supported by a strong medical technology ecosystem, advanced healthcare data capabilities, increasing AI research activities, and widespread adoption of precision medicine approaches.
Latin America accounted for approximately 3.5% of the global market in 2025 and was valued at around USD 65.1 million. The regional market is supported by expanding healthcare digitization programs, increasing demand for efficient diagnostic imaging solutions, rising chronic disease burden, and growing investments in healthcare infrastructure development.
Market Intelligence Overview (Historical, Current, Forecast):
Brazil accounted for approximately 32.9 % of the Latin America market in 2025 and was valued at nearly USD 21.4 million. The market benefits from growing adoption of AI-enabled radiology platforms, increasing demand for cancer diagnostics, expansion of private diagnostic networks, and rising healthcare technology investments.
Mexico accounted for approximately 23.5 % of the Latin America market in 2025 and was valued at nearly USD 15.3 million. Market expansion is driven by modernization of healthcare infrastructure, increasing chronic disease prevalence, growing digital imaging adoption, and expansion of private healthcare services.
Argentina represented approximately 10.6 % of the Latin America market in 2025 and was valued at around USD 6.9 million. The market is supported by increasing healthcare informatics adoption, growing demand for diagnostic efficiency, expansion of medical AI research activities, and rising utilization of advanced imaging technologies.
Chile represented approximately 8.6 % of the Latin America market in 2025 and was valued at around USD 5.6 million. Market growth is driven by healthcare digital innovation programs, increasing use of electronic health records, rising focus on diagnostic accuracy, and growing precision medicine initiatives.
Colombia accounted for approximately 5.2 % of the Latin America market in 2025 and was valued at nearly USD 3.3 million. The market benefits from healthcare modernization efforts, increasing investments in diagnostic services, growing chronic disease management requirements, and rising adoption of digital healthcare solutions.
Peru represented approximately 4.3 % of the Latin America market in 2025 and was valued at around USD 2.8 million. Market expansion is supported by healthcare infrastructure development, increasing awareness of early diagnosis, growing diagnostic imaging capacity, and government initiatives focused on healthcare modernization.
|
Company |
Estimated Market Share (%) |
|
GE HealthCare |
14.2% |
|
Microsoft |
11.5% |
|
Canon Medical Systems USA, Inc. |
9.8% |
|
Tempus |
8.6% |
|
Viz.ai, Inc. |
7.5% |
(Source: https://techcommunity.microsoft.com/blog/healthcareandlifesciencesblog/expanding-healthcare-ai-models-to-new-modalities-and-capabilities/4390410)
(Source: https://www.madrasmedicalmission.org.in/media/mmm-launches-centre-for-cardiac-care/)
Our research framework segments the AI in Medical Imaging market by Technology, Application, Modality, End-use and key regional markets
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
|
Key Report Attributes |
Details |
|
Years Considered |
2022 to 2035 |
|
Market Size 2025 |
USD 1862.4 Million |
|
Market Size 2035 |
USD 35285.6 Million |
|
Historical CAGR % (Growth rate) |
XX% from 2022 to 2025 |
|
Futuristic CAGR % (Growth rate) |
34.2% from 2026 to 2035 |
|
Segments Covered |
· By Technology · By Application · By Modality · By End-Use |
|
Regions Covered |
· North America · Europe · Asia Pacific · Latin America · Middle East & Africa |
|
Countries Covered |
USA; Canada; Germany; United Kingdom; France; Italy; Spain; Switzerland; Netherlands; China; India; Japan; South Korea; Singapore; Australia; Thailand; Malaysia; Philippines; Indonesia; Saudi Arabia; United Arab Emirates ; South Africa; Egypt; Israel; Brazil; Mexico; Argentina; Chile; Colombia ; Peru |
|
Competitive Landscape Overview |
· GE HealthCare · Microsoft · Digital Diagnostics Inc. · TEMPUS · Butterfly Network, Inc. · Advanced Micro Devices, Inc. · HeartFlow, Inc. · Enlitic, Inc. · Canon Medical Systems USA, Inc. · Viz.ai, Inc. · EchoNous, Inc. · HeartVista Inc. · Exo Imaging, Inc. · Nano-X Imaging Ltd. |
|
Flexible Report Customization |
The study can be customized based on geography, segment analysis, company profiling, competitive benchmarking, and strategic insights. |
|
Data Sources |
Primary and secondary sources used (Company filings, trade associations, Journals, Annual report, Publications, Surveys, Investor Presentations, and much more. |
Artificial Intelligence in Healthcare Market
· GE HealthCare
· Microsoft
· Digital Diagnostics Inc.
· TEMPUS
· Butterfly Network, Inc.
· Advanced Micro Devices, Inc.
· HeartFlow, Inc.
· Enlitic, Inc.
· Canon Medical Systems USA, Inc.
· Viz.ai, Inc.
· EchoNous, Inc.
· HeartVista Inc.
· Exo Imaging, Inc.
· Nano-X Imaging Ltd.
+44 1313818849
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USINDIA OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
408B, City Center, Hadapsar, Pune, India 411028
FOLLOW US
© Copyright 2026-27 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®